Wang Y, Shi J-P, Li Y-H, Yang W-H, Tian Y-J, Gao J, Li S-J
Department of Pediatric Rehabilitation, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Eur Rev Med Pharmacol Sci. 2016 May;20(16):3447-51.
We investigated the application of Alberta Infant Motor Scale (AIMS) in screening motor development delay in the follow-up of high-risk infants who were discharged from NICU, to explain the state of infants' motor development and propose early individualized intervention.
The study design was a randomized, single-blind trial by selecting patients between April 2015 and November 2015 in our hospital, children nerve recovery branch clinics and 77 cases of high-risk infants. We randomly divided the patients into observation group (39 cases) and control group (38 cases). To evaluate the application with AIMS, observation group was based on evaluation results for the first time to give rehabilitation training plan making, early intervention, control group according to the growth and development milestone in order to guide parents to take family training interval of 3 months.
While comparing the two groups of high-risk infants before the intervention, the months of age, gender, risk factors, it was found that the AIMS scores, each position AIMS scores did not show a significant difference in percentile (p>0.05). There was also no significant difference between two groups in the seat and stand AIMS scores before and after intervention (p>0.05). However, the comparison of two groups of high-risk infants after intervention in comparison showed that the observation group supine AIMS scores and AIMS scores were significantly higher than the control group (p<0.05). Prone position AIMS scores observation group was also significantly higher than that of the control group (p<0.01). The corresponding percentile for two groups after the intervention of AIMS scores was less than 10% of cases, which was significantly lower in the observation group (p<0.01).
AIMS can predict the development delay in high-risk infants, for improving the early hypernymic diagnosis and intervention.
探讨艾伯塔婴儿运动量表(AIMS)在新生儿重症监护病房(NICU)出院的高危婴儿随访中筛查运动发育迟缓的应用,以阐明婴儿运动发育状况并提出早期个体化干预措施。
本研究为随机、单盲试验,选取2015年4月至2015年11月在我院儿童神经康复科门诊的77例高危婴儿。将患者随机分为观察组(39例)和对照组(38例)。为评估AIMS的应用,观察组根据首次评估结果制定康复训练计划并进行早期干预,对照组根据生长发育里程碑指导家长进行家庭训练,间隔3个月。
比较两组高危婴儿干预前的月龄、性别、危险因素,发现AIMS总分、各体位AIMS得分的百分位数差异均无统计学意义(p>0.05)。两组干预前后坐位和站立位AIMS得分差异也无统计学意义(p>0.05)。然而,两组高危婴儿干预后的比较显示,观察组仰卧位AIMS得分和总分均显著高于对照组(p<0.05)。观察组俯卧位AIMS得分也显著高于对照组(p<0.01)。两组干预后AIMS得分对应的百分位数均小于10%的病例,观察组更低(p<0.01)。
AIMS可预测高危婴儿运动发育迟缓,有助于提高早期诊断及干预效果。